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Defects in filamin A (FLNA) gene could lead to low platelet counts and decreased surface expression of
glycoprotein (GP) Ibα. Here, we report and investigate the FLNA genomic alteration of a case with Bernard-Soulier
syndrome (BSS), a rare hereditary bleeding disorder caused by quantitative or qualitative abnormalities in the GP
Ib-IX-V receptor. DNA sequencing analysis reveals the presence of a GP Ibα c.987G > A mutation and a FLNA c.1582
G > A mutation in this patient. Transient transfection studies show that GP Ibα c.987G > A mutation abolishes the
surface expression of GP Ibα on the transfected CHO cells. On the other hand, abnormal responses to collagen,
including the platelet aggregation, secretion, and GP VI signaling pathways, are associated with FLNA c.1582G > A
mutation. Our findings confirm a central role for FLNA in platelet-adhesive functions. The interaction between FLNA
and GP Ibα in platelets deserves to be investigated.
Keywords: Bernard-Soulier syndrome, Platelets, Glycoprotein Ib-IX complex, Thrombocytopenia, MutationTo the Editor
Filamin A (FLNA), a dimeric actin crosslinking protein,
anchors the platelet adhesion glycoprotein (GP)Ib-IX-V
receptor to actin cytoskeleton. The GP Ibα-FLNA inter-
action is essential for the platelet adhesion to von Will-
ebrand factor that binds the GP Ib-IX-V receptor, for
normal signal transduction reactions involved in platelet
activation, and for maintaining normal platelet shape
and integrity [1]. The absence of or mutations in the GP
Ib-IX-V receptor or FLNA gene is responsible for
Bernard-Soulier syndrome (BSS) or macrothrombocyto-
penia [2], respectively. We described here a female BSS
case with FLNA mutation, showing her platelet func-
tional defects in the platelet aggregation, secretion, and
GP VI signaling pathways.
Patient’s platelet counts ranged between 20 and 30 ×
109/L, and enlarged platelets were observed in her blood
film. Platelet aggregation on ristocetin was null. Collagen
was decreased to induce platelet aggregation (0.5 μg/ml,
17 %; 1 μg/ml, 37 % versus 45 %, 70 % of controls). The
GPVI-specific agonist, convulxin, was also decreased* Correspondence: zwang201411@126.com
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creativecommons.org/publicdomain/zero/1.0/(400 PM, 10 %; 800 PM, 40 % versus 55 %, 70 % of con-
trols). Platelets released 33–86 % less ATP than control
platelets (Fig. 1a). The GP Ibα expression was practically
undetectable on the platelet surface. DNA sequencing
analysis revealed the presence of a new GP Ibα c.987G >
A mutation in a homozygous state and a FLNA c.1582
G > A mutation in a heterozygous state (Fig. 1b).
To establish that GP Ibα c.987G > A mutation was re-
sponsible for the lack of GP Ibα surface expression in
the patient’s platelets, we expressed in Chinese hamster
ovary (CHO) cells the mutant or normal GP Ibα cDNA
together with normal human cDNAs of GP Ibβ and
GPIX. Only trace amounts of GP Ibα and GPIX was de-
tected on CHO cells harboring the mutation, but trun-
cated GP Ibα and normal GPIX was present in the CHO
cell lysates (Fig. 1c). Together, these data could suggest
shorten GP Ibα and GPIX were synthesized, but failed to
be anchored and inserted into the plasma membrane.
A question raised by our observation was that patient’s
platelet responses to collagen were impaired, despite a
normal amount of platelet GPVI and FcRγ chain in her
platelets. Several lines of evidence demonstrated that
FLNA acted as a signaling scaffold for GPVI through
interaction with tyrosine kinase Syk [3]. In our study,distributed under the terms of the Creative Commons Attribution License
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Fig. 1 The effect of GP Ibα c.987G > A mutation and FLNA c.1582G > A mutation on the platelet functions. a Platelet aggregation and secretion
induced by collagen, convulxin (Cvx) and ADP. Aggregations of patient were expressed as the percentage change in light transmission. The levels
of ATP release were expressed as the amount of ATP released (nmol). Traces were representative of at least 2 experiments. b Part of the GP Ibα
gene sequence with the c.987G > A mutation and FLNA gene sequence with the c.1582G > A mutation. c Flow cytometric analysis and
immunoblotting analysis of GP Ibα and GPIX expression on transfected CHO cells. (white curve) CHO cells incubated with specific MoAb against
GP Ibα (SZ2) or GPIX (SZ1), (gray curve) CHO cells with vectors pcDNA 3.1(−) incubated with mouse IgG. WT means wild-type GP Ibα; MT means
mutant GP Ibα. d The level and distribution of FLNA using a monoclonal antibody specific for the C-terminal FLNA. Fluorescent microscopy
showed that FLNA was mostly found in a peripheral layer, which was similar with that of normal controls. These results were representative of at
least 2 independent experiments. e Platelet signaling induced by convulxin (Cvx).Washed platelets in suspension were activated by Cvx (400 PM)
in the absence of stirring. Tyrosine phosphorylation of Syk (Syk-P) and LAT (LAT-P) was assessed by immunoblotting with an anti–Syk-P and
anti–LAT-P, respectively. These results were representative of at least 3 independent experiments. C means control; P means patient
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detected in the patient’s platelets (Fig. 1d). However, the
phosphorylation of Syk was low (41 % of control) in the
platelet signaling pathway of GPVI induced by Cvx (400
pmol/L). Similarly, the phosphorylation of LAT, a direct
substrate of Syk, was decreased (45 % of control) (Fig. 1e).
FLNA could bind to the tyrosine kinase Syk through its
immunoglobulin-like repeat 3–5 in platelets [4]. In our
patient, the identified FLNA c.1582G > A, an Ig repeat 3
mutation, interfered with the Ig repeats engaged in signal-
ing of GPVI–collagen interaction. In turn, platelet aggre-
gation and ATP secretion on collagen was interrupted.
We thus conclude that abnormal responses to collagen
were associated with FLNA c.1582G > A mutation.
To the best of our knowledge, this was the first re-
port of a FLNA mutation causing abnormal response
to collagen in a BSS patient. According to our results,
we demonstrated that the synergistic effect of both GP
Ibα c.987G > A mutation and FLNA c.1582G > A mu-
tation could lead to the platelet functional alteration,including aggregation, secretion, and the GPVI signal-
ing pathway. The relationship between GP Ibα and
FLNA should constitute an area of interest for future
studies.
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